Year |
Citation |
Score |
2022 |
Catto JWF, Khetrapal P, Ricciardi F, Ambler G, Williams NR, Al-Hammouri T, Khan MS, Thurairaja R, Nair R, Feber A, Dixon S, Nathan S, Briggs T, Sridhar A, Ahmad I, ... ... Blick C, et al. Effect of Robot-Assisted Radical Cystectomy With Intracorporeal Urinary Diversion vs Open Radical Cystectomy on 90-Day Morbidity and Mortality Among Patients With Bladder Cancer: A Randomized Clinical Trial. Jama. PMID 35569079 DOI: 10.1001/jama.2022.7393 |
0.704 |
|
2015 |
Blick C, Ramachandran A, McCormick R, Wigfield S, Cranston D, Catto J, Harris AL. Identification of a hypoxia-regulated miRNA signature in bladder cancer and a role for miR-145 in hypoxia-dependent apoptosis. British Journal of Cancer. 113: 634-44. PMID 26196183 DOI: 10.1038/bjc.2015.203 |
0.72 |
|
2013 |
Blick C, Ramachandran A, Wigfield S, McCormick R, Jubb A, Buffa FM, Turley H, Knowles MA, Cranston D, Catto J, Harris AL. Hypoxia regulates FGFR3 expression via HIF-1α and miR-100 and contributes to cell survival in non-muscle invasive bladder cancer. British Journal of Cancer. 109: 50-9. PMID 23778527 DOI: 10.1038/bjc.2013.240 |
0.722 |
|
2013 |
McCormick RI, Blick C, Ragoussis J, Schoedel J, Mole DR, Young AC, Selby PJ, Banks RE, Harris AL. miR-210 is a target of hypoxia-inducible factors 1 and 2 in renal cancer, regulates ISCU and correlates with good prognosis. British Journal of Cancer. 108: 1133-42. PMID 23449350 DOI: 10.1038/bjc.2013.56 |
0.554 |
|
2013 |
Ramachandran A, Betts G, Bhana S, Helme G, Blick C, Moller-Levet C, Saunders E, Valentine H, Pepper S, Miller CJ, Buffa F, Harris AL, West CM. An in vivo hypoxia metagene identifies the novel hypoxia inducible factor target gene SLCO1B3. European Journal of Cancer (Oxford, England : 1990). 49: 1741-51. PMID 23352438 DOI: 10.1016/j.ejca.2012.12.003 |
0.352 |
|
2012 |
Blick C, Hall P, Pwint T, Al-Terkait F, Crew J, Powles T, Macaulay V, Munro N, Douglas D, Kilbey N, Protheroe A, Chester JD. Accelerated methotrexate, vinblastine, doxorubicin, and cisplatin (AMVAC) as neoadjuvant chemotherapy for patients with muscle-invasive transitional cell carcinoma of the bladder. Cancer. 118: 3920-7. PMID 22614698 DOI: 10.1002/Cncr.26675 |
0.684 |
|
2012 |
Blick CG, Nazir SA, Mallett S, Turney BW, Onwu NN, Roberts IS, Crew JP, Cowan NC. Evaluation of diagnostic strategies for bladder cancer using computed tomography (CT) urography, flexible cystoscopy and voided urine cytology: results for 778 patients from a hospital haematuria clinic. Bju International. 110: 84-94. PMID 22122739 DOI: 10.1111/j.1464-410X.2011.10664.x |
0.687 |
|
2012 |
Charlesworth PJS, Gray RHR, Blick C, Kilbey N, Protheroe A, Crew JP. Early recurrence of non-muscle invasive bladder cancer as a clinical marker of a poor prognosis and cancer-specific survival British Journal of Medical and Surgical Urology. 5: 284-288. DOI: 10.1016/j.bjmsu.2012.01.003 |
0.724 |
|
2011 |
Blick C, McCormick R, Ramachandran A, Cranston D, Catto J, Harris A. 495 THE HYPOXIC REGULATION OF FGFR3 IN NON MUSCLE INVASIVE BLADDER CANCER European Urology Supplements. 10: 167. DOI: 10.1016/S1569-9056(11)60486-7 |
0.468 |
|
2010 |
Favaro E, Ramachandran A, McCormick R, Gee H, Blancher C, Crosby M, Devlin C, Blick C, Buffa F, Li JL, Vojnovic B, Pires das Neves R, Glazer P, Iborra F, Ivan M, et al. MicroRNA-210 regulates mitochondrial free radical response to hypoxia and krebs cycle in cancer cells by targeting iron sulfur cluster protein ISCU. Plos One. 5: e10345. PMID 20436681 DOI: 10.1371/Journal.Pone.0010345 |
0.566 |
|
2009 |
Patel NS, Muneer A, Blick C, Arya M, Harris AL. Targeting vascular endothelial growth factor in renal cell carcinoma. Tumour Biology : the Journal of the International Society For Oncodevelopmental Biology and Medicine. 30: 292-9. PMID 19940550 DOI: 10.1159/000260241 |
0.606 |
|
2009 |
MacGregor T, Patel N, Blick C, Arya M, Muneer A. Is there a role for cardiopulmonary exercise testing before major urological surgery. Bju International. 104: 579-80. PMID 19426186 DOI: 10.1111/j.1464-410X.2009.08517.x |
0.439 |
|
2007 |
Blick C, Jones A, Fawcett DP. Clinically significant prostate cancer found incidentally in radical prostatectomy specimens. Bju International. 99: 1170. PMID 17437450 DOI: 10.1111/j.1464-410X.2007.06895_4.x |
0.536 |
|
Show low-probability matches. |